The apolipoprotein E and β-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 11, 1997, Pages 2880-2884

  Kessler, Christof ^a   Spitzer, Carsten ^a   Stauske, Dorothea ^a   Mende, Sabine ^a   Stadimüller, Jörg ^b   Walther, Reinhard ^a,b   Rettig, Rainer ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b Technol Transfer Unit Biotechnology   (Germany)

Author keywords

apoE; Genetics; Polymorphisms; Stroke; fibrinogen

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENETIC ANALYSIS; GENOTYPE; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; STROKE; VASCULAR DISEASE;

EID: 0031444185     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.11.2880     Document Type: Article

References (20)

1. World Development Report. Investing in Health. New York: Oxford University Press; 1993.
2. Bonita R, Stewart A, Beaglehole R. International trends in stroke mortality. 1970-1985. Stroke. 1990;21:989-992.
3. Kanter MC, Sherman DG. Strategies for preventing stroke. Curr Opin Neurol Neurosurg. 1993;6:60-65.
4. Khaw KT. Epidemiology of stroke. J Neurol Neurosurg Psychiatry 1996;61:333-338.
5. Prospective Studies Collaboration. Cholesterol, diastolic blood pressure, and stroke: 13000 strokes in 450000 people in 45 prospective cohorts. Lancet. 1995;346:1647-1653.
6. Kiely DK, Wolf PA, Cupples LA, Beiser AS, Myrs RH. Familial aggregation of stroke: the Framingham study. Stroke. 1993;24:1366-1371.
7. Graffagnino C, Gasecki AP, Dog GS, Hachinski VC. The importance of family history in cerebrovascular disease. Stroke. 1994;25:1599-1604.
8. Sing CF, Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet. 1985;37:268-285.
9. Eto M, Watanabe K, Ishii K. Reciprocal effects of apolipoprotein E alleles (E2 and E4) on plasma lipid levels in normolipidemic subjects. Clin Genet. 1986;29:477-484.
10. Reilly SL, Ferrell RE, Kottke BA, Kamboh MI, Sing CF. The gender-specific apolipoprotein E genotype influence on the distribution of lipids and apolipoproteins in the population of Rochester, Minnesota. I. Pleiotropic effects on means and variances. Am J Hum Genet. 1991;49:1155-1166.
11. Kosunen O, Talasniemi S, Lehtovirta M, Heinonen O, Helisalmi S, Mannermaa A, Paljärvi L, Ryynänen M, Riekkinen PJ, Soininen H. Relation of coronary atherosclerosis and apolipoprotein E genotypes in Afeheimer patients. Stroke. 1995;26:743-748.
12. Hixson JE, Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Apolipoprotein E polymorphism affects atherosclerosis in young males. Arterioscler Thromb. 1991;11:1237-1244.
13. Wang XL, McCredie RM, Wilcken DEL. Polymorphism of the apolipoprotein E gene and severity of coronary artery disease defined by angiography. Arterioscler Thromb Vasc Biol. 1995;15:1030-1034.
14. Couderc R, Mahieux F, Balilleul S, Fenelon G, Mary R, Fermanian J. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease: a case-control study. Stroke. 1993;24:661-664.
15. Pedro-Botet J, Senti M, Nogues X, Rubies-Prat J, Roquer J, D'Olhaberriague L, Olive J. Lipoprotein and apolipoprotein profile in men with ischemic stroke: role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke. 1992;23:1556-1562.
16. Kuusisto J, Mykkanen L, Kervinen K, Kesaniemi YA, Laakso M. Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arterioscler Thromb Vasc Biol. 1995;15:1280-1286.
17. Heinrich J, Assmann G. Fibrinogen and cardiovascular risk. J Cardiovasc Risk. 1995;2:197-205.
18. DiMinno G, Mancini M. Measuring plasma fibrinogen to predict stroke and myocardial infarction. Arteriosclerosis. 1990;10:1-7.
19. Lip GY. Fibrinogen and cardiovascular disorders. Q J Med. 1995;88:155-165.
20. Wilhemsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984;311:501-505.